ADMET-score - a comprehensive scoring function for evaluation of chemical drug-likeness
- PMID: 30774861
- PMCID: PMC6350845
- DOI: 10.1039/c8md00472b
ADMET-score - a comprehensive scoring function for evaluation of chemical drug-likeness
Abstract
Chemical absorption, distribution, metabolism, excretion, and toxicity (ADMET), play key roles in drug discovery and development. A high-quality drug candidate should not only have sufficient efficacy against the therapeutic target, but also show appropriate ADMET properties at a therapeutic dose. A lot of in silico models are hence developed for prediction of chemical ADMET properties. However, it is still not easy to evaluate the drug-likeness of compounds in terms of so many ADMET properties. In this study, we proposed a scoring function named the ADMET-score to evaluate drug-likeness of a compound. The scoring function was defined on the basis of 18 ADMET properties predicted via our web server admetSAR. The weight of each property in the ADMET-score was determined by three parameters: the accuracy rate of the model, the importance of the endpoint in the process of pharmacokinetics, and the usefulness index. The FDA-approved drugs from DrugBank, the small molecules from ChEMBL and the old drugs withdrawn from the market due to safety concerns were used to evaluate the performance of the ADMET-score. The indices of the arithmetic mean and p-value showed that the ADMET-score among the three data sets differed significantly. Furthermore, we learned that there was no obvious linear correlation between the ADMET-score and QED (quantitative estimate of drug-likeness). These results suggested that the ADMET-score would be a comprehensive index to evaluate chemical drug-likeness, and might be helpful for users to select appropriate drug candidates for further development.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6350845/bin/c8md00472b-f1.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6350845/bin/c8md00472b-f2.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6350845/bin/c8md00472b-f3.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6350845/bin/c8md00472b-f4.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6350845/bin/c8md00472b-f5.gif)
![Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6350845/bin/c8md00472b-f6.gif)
![Fig. 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6350845/bin/c8md00472b-f7.gif)
Similar articles
-
DBPP-Predictor: a novel strategy for prediction of chemical drug-likeness based on property profiles.J Cheminform. 2024 Jan 5;16(1):4. doi: 10.1186/s13321-024-00800-9. J Cheminform. 2024. PMID: 38183072 Free PMC article.
-
A drug-likeness toolbox facilitates ADMET study in drug discovery.Drug Discov Today. 2020 Jan;25(1):248-258. doi: 10.1016/j.drudis.2019.10.014. Epub 2019 Nov 6. Drug Discov Today. 2020. PMID: 31705979 Review.
-
ADMETopt: A Web Server for ADMET Optimization in Drug Design via Scaffold Hopping.J Chem Inf Model. 2018 Oct 22;58(10):2051-2056. doi: 10.1021/acs.jcim.8b00532. Epub 2018 Oct 9. J Chem Inf Model. 2018. PMID: 30251842
-
ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database.J Cheminform. 2018 Jun 26;10(1):29. doi: 10.1186/s13321-018-0283-x. J Cheminform. 2018. PMID: 29943074 Free PMC article.
-
The application of in silico drug-likeness predictions in pharmaceutical research.Adv Drug Deliv Rev. 2015 Jun 23;86:2-10. doi: 10.1016/j.addr.2015.01.009. Epub 2015 Feb 7. Adv Drug Deliv Rev. 2015. PMID: 25666163 Review.
Cited by
-
Biotechnological potential of actinomycetes in the 21st century: a brief review.Antonie Van Leeuwenhoek. 2024 May 24;117(1):82. doi: 10.1007/s10482-024-01964-y. Antonie Van Leeuwenhoek. 2024. PMID: 38789815 Review.
-
Identification of natural compounds (proanthocyanidin and rhapontin) as high-affinity inhibitors of SARS-CoV-2 Mpro and PLpro using computational strategies.Arch Med Sci. 2021 Mar 20;20(2):567-581. doi: 10.5114/aoms/133706. eCollection 2024. Arch Med Sci. 2021. PMID: 38757037 Free PMC article.
-
Abrogation of ORF8-IRF3 binding interface with Carbon nanotube derivatives to rescue the host immune system against SARS-CoV-2 by using molecular screening and simulation approaches.BMC Chem. 2024 May 11;18(1):99. doi: 10.1186/s13065-024-01185-4. BMC Chem. 2024. PMID: 38734638 Free PMC article.
-
Synthesis, Pharmacokinetic Profile, Anticancer Activity and Toxicity of the New Amides of Betulonic Acid-In Silico and In Vitro Study.Int J Mol Sci. 2024 Apr 20;25(8):4517. doi: 10.3390/ijms25084517. Int J Mol Sci. 2024. PMID: 38674101 Free PMC article.
-
Aminoguanidine-based bioactive proligand as AIEE probe for anticancer and anticovid studies.RSC Adv. 2024 Apr 25;14(19):13654-13668. doi: 10.1039/d4ra00554f. eCollection 2024 Apr 22. RSC Adv. 2024. PMID: 38665490 Free PMC article.
References
LinkOut - more resources
Full Text Sources